← FDA DRUG APPROVALS

FDA ANDA · ANDA217076

FERRIC CARBOXYMALTOSE

Sponsor: MYLAN

APPLICATION
ANDA217076
TYPE
ANDA
ORIGINAL APPROVAL
2026-06-25
LATEST ACTION
2026-06-25
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

FERRIC CARBOXYMALTOSEPrescription
FERRIC CARBOXYMALTOSE 1GM IRON/20ML (50MG IRON/ML) · SOLUTION · INTRAVENOUS

Approval history

2026-06-25UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →